Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Grazia Ferraro

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
European Journal of Medicinal Chemistry|December 28, 2022
Identification of 2,4,5-trisubstituted-2,4-dihydro-3H-1,2,4-triazol-3-one-based small molecules as selective BRD9 bindersEster Colarusso, Sara Ceccacci, Maria Chiara Monti, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 8, 2026
Design and evaluation of dual-functional aptamer-peptide conjugates as a platform for targeted cancer therapySimona Marzano, Maria Grazia Ferraro, Nicola Grasso, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 12, 2021
Supplementation with ribonucleotide-based ingredient (Ribodiet®) lessens oxidative stress, brain inflammation, and amyloid pathology in a murine model of AlzheimerAnella Saviano, Gian Marco Casillo, Federica Raucci, et al.
Scientific Reports|May 9, 2019
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancerMarialuisa Piccolo, Gabriella Misso, Maria Grazia Ferraro, et al.
Journal of Medicinal Chemistry|January 1, 2025
Design, Synthesis, and Anticancer Activity of Drug-like Iron Chelators/G-Quadruplex Binders as Synergic Dual Targeting AgentsMarialuisa Piccolo, Camilla Russo, Valentina Arciuolo, et al.
Archiv Der Pharmazie|December 18, 2024
5-methyl-2-carboxamidepyrrole-based novel dual mPGES-1/sEH inhibitors as promising anticancer candidatesEster Colarusso, Gianluigi Lauro, Marianna Potenza, et al.
European Journal of Medicinal Chemistry|July 15, 2026
Repositioning of 3-(isoxazol-3-yl)thiazolidin-4-one-based compounds via Inverse Virtual Screening: discovery of new ERα inhibitors with in vitro activity in breast cancer modelsEster Colarusso, Simona De Vita, Eleonora Boccia, et al.
European Journal of Pharmacology|February 28, 2026
Involvement of serotonin receptor 7 in synaptic dysfunctions in a mouse model of Autism Spectrum DisorderKardelen Dalim Filiz, Natalia Abate, Amelia Pizzella, et al.
Cancers|November 11, 2022
MicroRNAs' Crucial Role in Salivary Gland Cancers' Onset and PrognosisMarco Bocchetti, Piera Grisolia, Federica Melisi, et al.
ACS Pharmacology & Translational Science|July 15, 2026
Toward a Therapy for Autism Spectrum Disorder: The Formyl Peptide Receptor 2 Agonist MR-39 Supports Synaptic Health in the BTBR Mouse and Features a Favorable Safety ProfileDaniele Vitone, Fabio Francavilla, Maria Grazia Ferraro, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
European Journal of Medicinal Chemistry|December 28, 2022
Identification of 2,4,5-trisubstituted-2,4-dihydro-3H-1,2,4-triazol-3-one-based small molecules as selective BRD9 bindersEster Colarusso, Sara Ceccacci, Maria Chiara Monti, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 8, 2026
Design and evaluation of dual-functional aptamer-peptide conjugates as a platform for targeted cancer therapySimona Marzano, Maria Grazia Ferraro, Nicola Grasso, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 12, 2021
Supplementation with ribonucleotide-based ingredient (Ribodiet®) lessens oxidative stress, brain inflammation, and amyloid pathology in a murine model of AlzheimerAnella Saviano, Gian Marco Casillo, Federica Raucci, et al.
Scientific Reports|May 9, 2019
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancerMarialuisa Piccolo, Gabriella Misso, Maria Grazia Ferraro, et al.
Journal of Medicinal Chemistry|January 1, 2025
Design, Synthesis, and Anticancer Activity of Drug-like Iron Chelators/G-Quadruplex Binders as Synergic Dual Targeting AgentsMarialuisa Piccolo, Camilla Russo, Valentina Arciuolo, et al.
Archiv Der Pharmazie|December 18, 2024
5-methyl-2-carboxamidepyrrole-based novel dual mPGES-1/sEH inhibitors as promising anticancer candidatesEster Colarusso, Gianluigi Lauro, Marianna Potenza, et al.
European Journal of Medicinal Chemistry|July 15, 2026
Repositioning of 3-(isoxazol-3-yl)thiazolidin-4-one-based compounds via Inverse Virtual Screening: discovery of new ERα inhibitors with in vitro activity in breast cancer modelsEster Colarusso, Simona De Vita, Eleonora Boccia, et al.
European Journal of Pharmacology|February 28, 2026
Involvement of serotonin receptor 7 in synaptic dysfunctions in a mouse model of Autism Spectrum DisorderKardelen Dalim Filiz, Natalia Abate, Amelia Pizzella, et al.
Cancers|November 11, 2022
MicroRNAs' Crucial Role in Salivary Gland Cancers' Onset and PrognosisMarco Bocchetti, Piera Grisolia, Federica Melisi, et al.
ACS Pharmacology & Translational Science|July 15, 2026
Toward a Therapy for Autism Spectrum Disorder: The Formyl Peptide Receptor 2 Agonist MR-39 Supports Synaptic Health in the BTBR Mouse and Features a Favorable Safety ProfileDaniele Vitone, Fabio Francavilla, Maria Grazia Ferraro, et al.
Pageof 5